{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:03:19Z","timestamp":1784768599325,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"he earmarked fund for Hebei Agriculture Research System (HARS), China","award":["HBCT2024220208"],"award-info":[{"award-number":["HBCT2024220208"]}]},{"name":"S&T Program of Hebei, China","award":["21324801D"],"award-info":[{"award-number":["21324801D"]}]},{"name":"open project of Key laboratory of prevention and control agents for animal bacteriosis","award":["KLPCAAB-2025-04"],"award-info":[{"award-number":["KLPCAAB-2025-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Porcine epidemic diarrhea virus (PEDV) causes severe mortality in piglets, inflicting significant economic losses globally. Nanobodies (Nbs) offer distinct advantages over conventional antibodies for disease intervention. This study aimed to develop neutralizing Nbs against the PEDV spike (S) protein. We constructed a eukaryotic plasmid encoding the S protein of the CH-HB2-2018 strain and expressed it in HEK-293\u00a0F cells. Following alpaca immunization with the purified S protein, a phage display library was constructed. Biopanning yielded 70 unique Nbs based on CDR diversity, with 67 confirmed as specific binders via ELISA and Western blot. Further characterization using immunofluorescence and flow cytometry identified 9 specific candidates. Microneutralization assays revealed that these candidates showed varying degrees of inhibition against PEDV replication in Vero cells. Notably, nanobody 3Nb17 exhibited the highest binding affinity and neutralizing titer. These findings highlight 3Nb17 as a promising candidate for developing novel PEDV diagnostic tools and therapeutics.<\/jats:p>","DOI":"10.1186\/s12917-026-05628-z","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:50:48Z","timestamp":1784767848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neutralizing nanobodies against porcine epidemic diarrhea virus: discovery and characterization"],"prefix":"10.1186","volume":"22","author":[{"given":"Mengya","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlan","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengsai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"5628_CR1","doi-asserted-by":"publisher","unstructured":"Zhang Y, Chen Y, Zhou J, Wang X, Ma L, Li J, Yang L, Yuan H, Pang D, Ouyang H. Porcine epidemic diarrhea virus: an updated overview of virus epidemiology, virulence variation patterns and virus-host interactions. Viruses. 2022;14(11):2434. https:\/\/doi.org\/10.3390\/v14112434.","DOI":"10.3390\/v14112434"},{"key":"5628_CR2","doi-asserted-by":"publisher","unstructured":"Hu G, Kang Q, Luo Z, Geng R, Zhao Z, Peng O, Zou C, Feng S, Cao Y, Shen H, et al. Characterization and pathogenic evaluation of a novel S-INDEL PEDV CH\/JSHA2024 isolated in China. Anim Dis. 2025;5:19. https:\/\/doi.org\/10.1186\/s44149-025-00174-x.","DOI":"10.1186\/s44149-025-00174-x"},{"key":"5628_CR3","doi-asserted-by":"publisher","unstructured":"Huang B, Gu G, Zhang Y, Chen Z, Tian K. Molecular and structural evolution of porcine epidemic diarrhea virus. Animals. 2022;12(23):3388. https:\/\/doi.org\/10.3390\/ani12233388.","DOI":"10.3390\/ani12233388"},{"key":"5628_CR4","doi-asserted-by":"publisher","unstructured":"Luo H, Liang Z, Lin J, Wang Y, Liu Y, Mei K, Zhao M, Huang S. Research progress of porcine epidemic diarrhea virus S protein. Front Microbiol. 2024;15:1396894. https:\/\/doi.org\/10.3389\/fmicb.2024.1396894.","DOI":"10.3389\/fmicb.2024.1396894"},{"issue":"6","key":"5628_CR5","doi-asserted-by":"publisher","first-page":"e00549","DOI":"10.1128\/jvi.00549-23","volume":"97","author":"C Zhou","year":"2023","unstructured":"Zhou C, Liu Y, Wei Q, Chen Y, Yang S, Cheng A, Zhang G. HSPA5 Promotes attachment and internalization of porcine epidemic diarrhea virus through interaction with the spike protein and the endo-\/lysosomal pathway. J Virol. 2023;97(6):e00549\u201323. https:\/\/doi.org\/10.1128\/jvi.00549-23.","journal-title":"J Virol"},{"issue":"6","key":"5628_CR6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1134\/S0026893320060151","volume":"54","author":"TA Zaichuk","year":"2020","unstructured":"Zaichuk TA, Nechipurenko YD, Adzhubey AA, Onikienko SB, Chereshnev VA, Zainutdinov SS, Kochneva GV, Netesov SV, Matveeva OV. The challenges of vaccine development against betacoronaviruses: antibody dependent enhancement and Sendai virus as a possible vaccine vector. Mol Biol. 2020;54(6):812\u201326. https:\/\/doi.org\/10.1134\/s0026893320060151.","journal-title":"Mol Biol"},{"issue":"12","key":"5628_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/pathogens13121109","volume":"13","author":"EE Nakayama","year":"2024","unstructured":"Nakayama EE, Shioda T. Detrimental effects of anti-nucleocapsid antibodies in SARS-CoV-2 infection, reinfection, and the post-acute sequelae of COVID-19. Pathogens. 2024;13(12):1109. https:\/\/doi.org\/10.3390\/pathogens13121109.","journal-title":"Pathogens"},{"issue":"12","key":"5628_CR8","doi-asserted-by":"publisher","first-page":"e00273","DOI":"10.1128\/jvi.00273-17","volume":"91","author":"C Li","year":"2017","unstructured":"Li C, Li W, Lucio de Esesarte E, Guo H, van den Elzen P, Aarts E, van den Born E, Rottier PJM, Bosch B-J. Cell attachment domains of the porcine epidemic diarrhea virus spike protein are key targets of neutralizing antibodies. J Virol. 2017;91(12):e00273\u201317. https:\/\/doi.org\/10.1128\/jvi.00273-17.","journal-title":"J Virol"},{"key":"5628_CR9","doi-asserted-by":"publisher","unstructured":"Yu J, Sreenivasan C, Uprety T, Gao R, Huang C, Lee EJ, Lawson S, Nelson J, Christopher-Hennings J, Kaushik RS, et al. Piglet immunization with a spike subunit vaccine enhances disease by porcine epidemic diarrhea virus. NPJ Vaccines. 2021;6(1):22. https:\/\/doi.org\/10.1038\/s41541-021-00283-x.","DOI":"10.1038\/s41541-021-00283-x"},{"issue":"6","key":"5628_CR10","doi-asserted-by":"publisher","first-page":"e00347","DOI":"10.1128\/jvi.00347-25","volume":"99","author":"Q Qian","year":"2025","unstructured":"Qian Q, Zhao S, Yang L, Xing G, Chen Y, Liang C, Wang H, Li R, Qiao S, Wang A, et al. Palmitoylation enhances the stability of porcine epidemic diarrhea virus spike protein by antagonizing its degradation via chaperone-mediated autophagy to facilitate viral proliferation. J Virol. 2025;99(6):e00347\u201325. https:\/\/doi.org\/10.1128\/jvi.00347-25.","journal-title":"J Virol"},{"issue":"3","key":"5628_CR11","doi-asserted-by":"publisher","first-page":"e00018","DOI":"10.1128\/jvi.00018-25","volume":"99","author":"H Zhu","year":"2025","unstructured":"Zhu H, Lou J, Yang Z, Bai J, Jiang P, Wang X, Liu X. STT3B promotes porcine epidemic diarrhea virus replication by regulating N-glycosylation of PEDV S protein. J Virol. 2025;99(3):e00018\u201325. https:\/\/doi.org\/10.1128\/jvi.00018-25.","journal-title":"J Virol"},{"issue":"3","key":"5628_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/mba2.54","volume":"2","author":"Q Su","year":"2023","unstructured":"Su Q, Shi W, Huang X, Yin S, Yang X, Lu X. Recent advances of nanobody applications in diagnosis and detection. MedComm Biomater Appl. 2023;2(3):54. https:\/\/doi.org\/10.1002\/mba2.54.","journal-title":"MedComm Biomater Appl"},{"key":"5628_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jconrel.2023.12.041","volume":"366","author":"S Joly","year":"2024","unstructured":"Joly S, Augusto G, Mdzomba B, Meli I, Vogel M, Chan A, Pernet V. Nogo-A neutralization in the central nervous system with a blood-brain barrier-penetrating antibody. J Control Release. 2024;366:52\u201364. https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.041.","journal-title":"J Control Release"},{"issue":"9","key":"5628_CR14","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3390\/biom14091116","volume":"14","author":"Z Hao","year":"2024","unstructured":"Hao Z, Dong X, Zhang Z, Qin Z. A nanobody of PEDV S1 protein: Screening and expression in Escherichia coli. Biomolecules. 2024;14(9):1116. https:\/\/doi.org\/10.3390\/biom14091116.","journal-title":"Biomolecules"},{"issue":"4","key":"5628_CR15","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.3390\/ijms24044176","volume":"24","author":"H Tang","year":"2023","unstructured":"Tang H, Gao Y, Han J. Application progress of the single domain antibody in medicine. Int J Mol Sci. 2023;24(4):4176. https:\/\/doi.org\/10.3390\/ijms24044176.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5628_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/vaccines12040417","volume":"12","author":"J Wang","year":"2024","unstructured":"Wang J, Shi B, Chen H, Yu M, Wang P, Qian Z, Hu K, Wang J. Engineered multivalent nanobodies efficiently neutralize SARS-CoV-2 Omicron subvariants BA.1, BA.4\/5, XBB.1 BQ.1.1. Vaccines. 2024;12(4):417. https:\/\/doi.org\/10.3390\/vaccines12040417.","journal-title":"Vaccines"},{"issue":"2","key":"5628_CR17","doi-asserted-by":"publisher","first-page":"e0295823","DOI":"10.1128\/mbio.02958-23","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Fan B, Song X, Gao J, Guo R, Yi C, He Z, Hu H, Jiang J, Zhao L, et al. PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge. mBio. 2024;15(2):e0295823. https:\/\/doi.org\/10.1128\/mbio.02958-23.","journal-title":"mBio"},{"issue":"14","key":"5628_CR18","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1001\/jama.2014.12854","volume":"312","author":"JM Mark","year":"2014","unstructured":"Mark JM, David IB, Patricia W, Richard R, Evan A, Nadine R, Michelle D, Jack TS, Srilatha E, Paul S, et al. Serological Responses to an Avian Influenza A\/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant. JAMA. 2014;312(14):1409\u201319. https:\/\/doi.org\/10.1001\/jama.2014.12854.","journal-title":"JAMA"},{"key":"5628_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-61779-974-7_8","volume":"907","author":"C Vincke","year":"2012","unstructured":"Vincke C, Guti\u00e9rrez C, Wernery U, Devoogdt N, Hassanzadeh-Ghassabeh G, Muyldermans S. Generation of single domain antibody fragments derived from camelids and generation of manifold constructs. Methods Mol Biol. 2012;907:145\u201376. https:\/\/doi.org\/10.1007\/978-1-61779-974-7_8.","journal-title":"Methods Mol Biol"},{"key":"5628_CR20","doi-asserted-by":"crossref","unstructured":"Burleson FG, Chambers TM, Wiedbrauk DL. Virology: a laboratory manual. London: Academic Press; 1992. pp. 58\u201361.","DOI":"10.1016\/B978-0-12-144730-4.50015-1"},{"key":"5628_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27:493\u20137.","journal-title":"Am J Epidemiol"},{"key":"5628_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/978-1-61779-974-7_24","volume":"901","author":"S Hearty","year":"2012","unstructured":"Hearty S, Leonard P, O\u2019Kennedy R. Measuring antibody-antigen binding kinetics using surface plasmon resonance. Methods Mol Biol. 2012;901:411\u201342. https:\/\/doi.org\/10.1007\/978-1-61779-974-7_24.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"5628_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/vaccines12050557","volume":"12","author":"R Yu","year":"2024","unstructured":"Yu R, Dong S, Chen B, Si F, Li C. Developing next-generation live attenuated vaccines for porcine epidemic diarrhea using reverse genetic techniques. Vaccines. 2024;12(5):557. https:\/\/doi.org\/10.3390\/vaccines12050557.","journal-title":"Vaccines"},{"issue":"4","key":"5628_CR24","doi-asserted-by":"publisher","first-page":"e0123522","DOI":"10.1016\/j.virusres.2016.05.023","volume":"10","author":"Z Li","year":"2022","unstructured":"Lin CM, Saif LJ, Marthaler D, Wang Q. Evolution, antigenicity and pathogenicity of global porcine epidemic diarrhea virus strains. Virus Res. 2016;226:20\u201339. https:\/\/doi.org\/10.1016\/j.virusres.2016.05.023.","journal-title":"Microbiol Spectr"},{"key":"5628_CR25","doi-asserted-by":"publisher","first-page":"198045","DOI":"10.1016\/j.virusres.2020.198045","volume":"286","author":"K Jung","year":"2020","unstructured":"Jung K, Saif LJ, Wang Q. Porcine epidemic diarrhea virus (PEDV): An update on etiology, transmission, pathogenesis, and control strategies. Virus Res. 2020;286:198045. https:\/\/doi.org\/10.1016\/j.virusres.2020.198045.","journal-title":"Virus Res"},{"key":"5628_CR26","doi-asserted-by":"publisher","first-page":"699049","DOI":"10.1038\/s41564-020-00789-5","volume":"12","author":"S Ko","year":"2021","unstructured":"Lee WS, Wheatley AK, Kent SJ, DeKosky BJ. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. 2020;5(10):1185\u201391. https:\/\/doi.org\/10.1038\/s41564-020-00789-5.","journal-title":"Front Immunol"},{"issue":"3","key":"5628_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/vaccines7030077","volume":"7","author":"RA Weiss","year":"2019","unstructured":"Weiss RA, Verrips CT. Nanobodies that neutralize HIV. Vaccines. 2019;7(3):77. https:\/\/doi.org\/10.3390\/vaccines7030077.","journal-title":"Vaccines"},{"issue":"1","key":"5628_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-024-03259-8","volume":"24","author":"MH Abdolvahab","year":"2024","unstructured":"Abdolvahab MH, Karimi P, Mohajeri N, Abedini M, Zare H. Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies. Cancer Cell Int. 2024;24(1):67. https:\/\/doi.org\/10.1186\/s12935-024-03259-8.","journal-title":"Cancer Cell Int"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-026-05628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-026-05628-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-026-05628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:50:49Z","timestamp":1784767849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12917-026-05628-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5628"],"URL":"https:\/\/doi.org\/10.1186\/s12917-026-05628-z","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments in this study (specifically the alpaca immunization) were approved by the Experimental Animal Ethics Committee of Hebei Normal University of Science & Technology (Approval No. 2025009) and were conducted strictly in accordance with the Guide to the Care and Use of Experimental Animals. The alpaca used in this study was privately owned by the Qinhuangdao Wildlife Park, and informed consent was formally obtained from the park management for its use in this research.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"438"}}